Related Experiment Video
Updated: May 5, 2026
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Identification of novel rab27a/melanophilin blockers by pharmacophore-based virtual screening
Jong Young Joung1, Ha Yeon Lee, Jongil Park
1Bioinformatics and Molecular Design Research Center, Seoul, 120-749, Republic of Korea.
Abstract:
Melanocytes are unique cells that produce specific melanin-containing intracellular organelles called melanosomes. Melanosomes are transported from the perinuclear area of melanocytes toward the plasma membrane as they become more melanized in order to increase skin pigmentation. In this vesicular trafficking of melanosomes, Rab27a, melanophilin, and myosin Va play crucial roles in linking melanosomes to actin-based motors. To identify novel compounds to inhibit binding interface between Rab27a and melanophilin, a pharmacophore model was built based on a modeled 3D structure of the protein complex that describes the essential binding residues in the intermolecular interaction. A pharmacophore model was employed to screen a chemical library database. Finally, 25 virtual hits were selected for biological evaluations. The biological activities of 11 analogues were evaluated in a second assay. Two compounds were identified as having concentration-dependent inhibitory activity. By analyzing structure-activity relationships of derivatives of BMD-20, two hydroxyl functional groups were found to be critical for blocking the intermolecular binding between Rab27a and melanophilin.
Insights
Researchers identified novel compounds that inhibit melanosome transport by targeting the Rab27a-melanophilin interaction. Two compounds demonstrated concentration-dependent inhibitory activity, with specific hydroxyl groups crucial for blocking this binding.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- Melanocytes produce melanosomes for skin pigmentation.
- Melanosome transport involves Rab27a, melanophilin, and myosin Va.
- Inhibiting the Rab27a-melanophilin interaction is a potential therapeutic target.
Purpose of the Study:
- To identify novel compounds inhibiting the Rab27a-melanophilin binding interface.
- To develop a pharmacophore model for screening potential inhibitors.
Main Methods:
- A pharmacophore model was built based on the 3D structure of the Rab27a-melanophilin complex.
- A chemical library was screened using the pharmacophore model.
- Selected virtual hits underwent biological evaluation and structure-activity relationship analysis.
Main Results:
- 25 virtual hits were selected for initial evaluation.
- Two compounds exhibited concentration-dependent inhibitory activity against the target interaction.
- Two hydroxyl functional groups on BMD-20 derivatives were identified as critical for inhibition.
Conclusions:
- Novel compounds targeting the Rab27a-melanophilin interaction were identified.
- The study provides insights into structure-activity relationships for developing inhibitors.
- These findings could lead to new strategies for modulating skin pigmentation or related cellular processes.
